# C-072 — absorb main v139 + confirm honest cost exhaustion HOLD

**As-of:** 2026-10-04 12:30 Europe/Amsterdam (CEST / UTC+2)
**Branch:** `grok/cto-1`
**Trials appended by CTO:** 0. TRIAL_COUNT book **471**. Reserve 2025+: untouched. Live PREREG: none. Formal OPEN: empty.
**FREEZE OFF. Kill circuit ON. Track-3 PAUSED.**

## Sync since C-071 (`9847626`)

| Source | Tip | Delta |
|--------|-----|-------|
| main | `39a0401` NEXT_STEPS **v139** | Manager absorb C-071; U2 header `58e4499`; Faraday N180–N183 unchanged; HOLD Strateeg; TRIAL 471 |
| U2 | `257425c` | IDLE cycle 12:15 CEST absorb v139; TRIAL 471; no live PREREG (prior `58e4499`) |
| Faraday | idle `8575b15` / results `1e5a7f1` | hourly idle §10 sync v139/C-071; **no new N*** since N180–N183 FAIL |
| S2 | `0686061` (promote tip `e31d1b5`) | hourly HOLD note **v137**; EWC/XLU stay DEFER_NOT_PROMOTE |
| Strateeg (grok) | `e07617a` | stale GS01/GS02 research tip; Lane-B HOLD per Manager |
| CEO | `7cb6731` | no new D-* after D-104 |

## Deliverable (0 CTO trials)

1. **Absorb** main v139 into `grok/cto-1` (merge pre-absorb `909fbf8`).
2. **Reconfirm** C-050…C-071 exhaustion: `ok_new_authorize = 0` / `n_ok_new_authorize = 0` — no alle / COSTS / specs delta (md5 unchanged); do **not** invent RT/swap or re-authorize USDSEK/USDNOK/USDZAR (M5 4.74y refused) or SPN35/N25/EU50.
3. **No Lane-B OPEN / PREREG** — OPEN empty; C-048 nine closed; kill circuit ON; do not invent a pair.
4. **HOLD Strateeg** Lane-B until Debian honest cost row **or** S2 Lane-A survivor maps to an already-authorized leg without cloning N75–N183.
5. **S2** remains active novelty path (Lane-A Yahoo); EWC→EURUSD / XLU→US500 deferred (closed-17 legs).

## Unblock (not this cycle)

- Debian confirmed stock/crypto commission; EU50/FRA40 swap-snapshot year; SPN35/N25 native pre-2020-11; non-XAU metal €2/lot.
- S2 ≥2 NEW_FAMILY survivor on authorized mapped leg (not closed-book EURUSD/US500 clones).

## WakeParent

**QUIET** — routine absorb + confirm HOLD; no Sandro blocker / breakthrough.
